Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019

Network pharmacology studies on the effect of Chai-Ling decoction in coronavirus disease 2019

Background: Chai-Ling decoction (CLD), derived from a modification of Xiao-Chai-Hu (XCH) decoction and Wu-Ling-San (WLS) decoction, has been used to treat the early-stage of coronavirus disease 2019 (COVID-19). However, the mechanisms of CLD in COVID-19 remain unknown. In this study, the potential m...

Full description

Bibliographic Details
Main Authors: Lu Yang, Yu-Ting Li, Jing Miao, Li Wang, Hui Fu, Qin Li, Wei-Bo Wen, Zhai-Yi Zhang, Rui-Wen Song, Xiang-Guo Liu, Hong-Wu Wang, Huan-Tian Cui
Format: Article
Language:English
Published: Hong Kong Gold Orchid Science and Technology Co., Limited 2020-04-01
Series:Traditional Medicine Research
Subjects:
chai-ling decoction
coronavirus disease 2019
network pharmacology
molecular docking
severe acute respiratory syndrome coronavirus 2
angiotensin-converting enzyme 2
Online Access:https://www.tmrjournals.com/tmr/EN/10.12032/TMR20200324170

Internet

https://www.tmrjournals.com/tmr/EN/10.12032/TMR20200324170

Similar Items